{
    "source": "Twitter Web App",
    "entities": {
        "mentions": [
            {
                "start": 0,
                "end": 4,
                "username": "WHO",
                "id": "14499829"
            },
            {
                "start": 5,
                "end": 13,
                "username": "WHOWPRO",
                "id": "3794682452"
            },
            {
                "start": 14,
                "end": 23,
                "username": "WHOSEARO",
                "id": "1545915336"
            },
            {
                "start": 24,
                "end": 35,
                "username": "WHO_Europe",
                "id": "125403342"
            },
            {
                "start": 36,
                "end": 44,
                "username": "pahowho",
                "id": "20629893"
            },
            {
                "start": 45,
                "end": 53,
                "username": "WHOEMRO",
                "id": "259372802"
            },
            {
                "start": 54,
                "end": 62,
                "username": "WHOAFRO",
                "id": "544389588"
            }
        ]
    },
    "created_at": "2020-01-27T15:22:50.000Z",
    "id": "1221815837797027846",
    "text": "@WHO @WHOWPRO @WHOSEARO @WHO_Europe @pahowho @WHOEMRO @WHOAFRO WHO statement is incomplete: antibiotics may be required for treating secondary bacterial pulmonary infections in 2019-nCoV patients with pneumonia (in fact, they are used for that purpose)"
}